Dama Health

Ever had a patient on the highest MHT dose who still had menopausal symptoms, and another one on the lowest dose with significant side effects? Everyone reacts differently to exogenous hormones, but one way to personalise hormone prescriptions is to utilize pharmacokinetic data! Join us for an upcoming masterclass where our Chief Medical Advisor, Dr. Aaron Lazorwitz, MD, PhD (Associate Professor of OB/GYN at Yale & Pharmacogenomics Expert), will walk us through how to leverage pharmacokinetic data to bring more precision to our care. We will talk about how PK data can be useful for: 👉 Patients who “over-absorb” 👉 Understanding why patients have symptom relapses when you switch from one method to another 👉 How to find the “bioequivalent” alternative with more precision. Join us on September 29 at 6 PM ET for a practical, case-based discussion! If you've ever had a patient’s symptoms return after switching their estrogen formulation due to a shortage, this is the session for you! 🔗 Save your spot and get the replay with the link in the comments!

#Perimenopause & #Menopause treatment and resources have long been fragmented for providers. No central place for us to trust to manage a #woman’s symptoms, medications, labs, ext. Until #DamaHealth - founded by Elena Rueda and Paulina Cecula out of the #UK who saw that modern #LLMs failing to solve the problem - and built their own #Hormonehealth and Menopause LLM and tool to support providers to make more informed treatment decisions! And today after independent review of their product by a panel of Women’s Health Nurse Practitioners by NurseApproved, #DamaHealth received the NurseApproved Certification: NurseApproved: Tested & Trusted! The first such platform to be endorsed and trusted by #Nurses. We are so incredibly excited for the future of Dama Health and the impact they are going to have on supporting providers everywhere to better manage #WomensHealth. See the full #PressRelease below! #NursesOnLinkedIn #HealthcareOnLinkedIn #HypeWomen #AANP #NNPEN #AWHONN Lorraine Bock, DNP, FNP-BC, ENP-BC, FAANP Wendy Lin, FNP-C Robin Geiger, DNP, MSN, APRN, FNP-BC, NEA-BC, FADLN Stephanie Ahmed, DNP, NP-BC Darlene Sawicki, MSN, NP Michelle Doran, RN, BA, MS, DNP, NPD-BC Kelly Ayala, DNP, APRN, RN Kelley Muldoon Rieger MSN, PNP, FIEL Wendy Getz Chinelo A. Okoye FNP-C, CPNP-PC, FIEL Dawn Mutchko, DNP, APRN, FNP-C, CENP, CGNC, EBP-C, CPHQ, CLSS-GB, FAANP, FNAP Dr. Nikki SanMiguel-Stephens DNP, FNP-C Evidence-Based Advocate Selena Gilles, DNP, ANP-BC, CNEcl, ANEF, FNYAM, FADLN, FNAP, FAANP, FAAN Aurelie Catherine Cormier RN,MS ANP-BC Colleen Walsh-Irwin DNP, ANP-BC, AACC, EBP-C, FAANP, FAAN Diana Campion, MSN, APRN, ANP-C Lydia Jidkov Bongi Sibanda Professor Shafi Ahmed Zayna Khayat, Ph.D.

Big news: Dama Health just earned the NurseApproved Seal for Dama Assist, their clinical decision-support platform for hormone health and menopause care. Here's what made this result extraordinary. Every single nurse on the independent review panel rated Dama Assist as outperforming the tools they currently use in practice. Unanimous. In a space where clinicians have been cobbling together resources across multiple databases and guideline bodies just to make a single patient decision, that is a remarkable outcome. Menopause and hormone health are among the most underserved areas in medicine. Dama Health went deep in this specialty when most companies go broad, and the nurses who evaluated them validated that bet in a big way. This is exactly what the seal exists for. Congratulations to Elena Rueda and the entire Dama Health team -- this one was well earned. #nursesoflinkedin #nurses #womenshealth #menopause

Many clinicians use standard #MHT conversion charts for efficiency by simply looking up the patch dose, finding the "equivalent" gel, prescribing, and moving on. But this keeps the trial-and-error in MHT prescribing. Two formulations might look "equivalent" on a static chart, but their systemic exposure, peak serum levels, and clearance rates, in combination the patient’s context can dictate a different physiological response. Aaron Lazorwitz, MD, PhD (Associate Professor of OB/GYN at Yale & Pharmacogenomics Expert), will be giving us the lowdown on approaching MHT prescribing differently, with more precision. On Tuesday, Sept 29th at 6 PM ET, Dr. Lazorwitz will cover: → Navigating Shortages: Why standard charts fail us during drug shortages, and how to find true bioequivalent alternatives. → Precision Dosing: How to dose based on actual systemic drug exposure rather than the label on the box. → Clinical Troubleshooting: How to use PK data to manage non-responders, hypo/hyper-absorbers, and mitigate side effects. We’ll be walking through real clinical case studies to show you exactly how this looks in practice. If you’re a #clinician prescribing #hormones, join us as we break down how to actually integrate #pharmacokinetics into your #MHT prescribing approach. → Save your spot today: https://lnkd.in/eHeRbpyY

Join us for a FREE clinical masterclass on Estrogen Pharmacokinetics When Prescribing MHT with our Chief Medical Advisor, Aaron Lazorwitz, MD, PhD (Associate Professor of OB/GYN at Yale & Pharmacogenomics Expert). Whether it's navigating sudden drug shortages, managing non-responders, or dealing with patients who "just aren't absorbing" their transdermal estrogen, the standard MHT conversion charts we use today are too simplistic. This keeps the trial-and-error in menopause care. But, by understanding actual systemic drug exposure, we can bring true precision to menopause care. Aaron Lazorwitz, MD, PhD will walk us through: 👉 The clinical limitations of standard hormone conversion tables. 👉 How to translate estrogen pharmacokinetic curves into confident, individualized dosing decisions. 👉 Live clinical case demos: safely switching methods and troubleshooting hyper/hypo-absorbers. Who should attend? Clinicians who treat women day-to-day and want to move beyond trial-and-error MHT prescribing! 🗓️ Tuesday, Sept 29th at 6PM ET 📍 Register for free on Zoom Join us and bring your questions for the Q&A with Dr. Lazorwitz! #webinar #masterclass #pharmacokinetics #education #estrogen #hrt #mht #menopause #medicine #transdermal #clinicaltools

$216 Billion. What if a single medical intervention could save the US healthcare system $216 billion while massively improving quality of life? That intervention already exists: modern Menopause Hormone Therapy (#MHT). In our latest Dama #newsletter, we take a deep dive into this fantastic new cost-effectiveness study, and explore why new international guidelines are pushing a paradigm shift in the management of Premature Ovarian Insufficiency (#POI) and Early Menopause. 👉 Swipe for the headlines, and hit the link below to read the full breakdown! P.S. If you're a clinician and will be at the NPWH Conference or The Perry Academy Perimenopause Symposium later this month, please reach out or come find us. We'd love to connect with you there between Sept 23–25.

Did you know that perimenopause can start up to 10 years before your final period? 🤔 When we think of the transition to menopause, we usually picture hot flashes. But our brains are incredibly dense with estrogen receptors. When estrogen levels start to fluctuate wildly during perimenopause, the earliest symptoms are often neurological and psychological, not just physical. September is perimenopause awareness month and I'm extremely excited to learn more from these incredible clinicians about the nuances of perimenopause care at The Perimenopause symposium by Perry. At Dama Health the number one question we see clinicians asking Dama Assist is related to perimenopause as there is still so much to learn. If you're a clinician interested to continue learning and practice evidence-based and modern perimenopause care - this is not one to miss! 🎟️ Use PERI_SYMPOSIUM_DAMA_30 for a 30% off your ticket Perry, Laura Okafor, Magda Szmilewska, Paulina Cecula

I'm excited to be attending the 2026 NPWH Women's Healthcare Conference, September 23-25, in Richmond, Virginia! If you're an advanced practice provider or student passionate about women's and gender-related healthcare, join me for three days of evidence-based education, meaningful networking, and the opportunity to earn up to 39 CE contact hours. Hope to see you there! 🔗 Register here: https://lnkd.in/erYF_z9X #NPWH2026 #WomensHealth #NursePractitioner #ContinuingEducation #NPWH

We published a blog breaking down how clinicians are actually using Dama Assist, based on real usage data and real conversations. The number one use case isn't efficiency. It's thinking partnership. Clinicians are using it as a daily reasoning partner for complex cases, generating patient handouts in the same thread, stress-testing high-risk hormone therapy decisions, and catching knowledge gaps before they reach a patient. One Nurse Practitioner described it as feeling like sitting next to a women's health colleague. Generic AI defaults to conservative, often outdated, population-level guidance. Women's hormone health doesn't work that way, because the "average" answer is often the wrong answer for the patient sitting in front of you.